For instance, experimental models show that modification of insulin levels associated with glycemic dysregulation appears early during cancer development: Pancreatic carcinogenesis (Li, 2012) and breast cancer are preceded by modifications of blood insulin levels (Ferroni et al., 2016). Here, INS is linked to cancer.